Delcath Systems Inc (DCTH) Live Share Price, Invest From India

Delcath Systems Inc Stock Performance

as on October 31, 2025 at 1:29 am IST

Day's Low
Day's High
$9.15
Day's Price Range
$9.98
$9.4
2.66%
Downside
6.17%
Upside
52 Week's Low
52 Week's High
$8.87
52-Week Price Range
$18.23
$9.4
5.64%
Downside
93.94%
Upside

Delcath Systems Inc share price movements today

Previous Close: $9.72
Open: $9.68
Volume: 1.0M
Day's Low - High: $9.15 - $9.98
52 Week Low - High: $8.87 - $18.23

Delcath Systems Inc Historical Returns

1 Month Return: -9.58 %
3 Month Return: -11.07 %
1 Year Return: -6.99 %
3 Year Return: + 241.05 %
5 Year Return: -9.24 %

Delcath Systems Inc Stock Fundamentals & Key Indicators

Check Delcath Systems Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$355.1M

EPS (TTM)

0.086

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

112.78

Industry PE ratio

PEG Ratio

EBITDA

5.2M

Revenue (TTM)

70.2M

Profit Margin

3.18%

Return On Equity TTM

3.57%

Delcath Systems Inc Stock Valuation

Track how Delcath Systems Inc P/E has moved over time to understand its valuation trends.

Delcath Systems Inc in the last 5 years

Overview
Trends

Lowest (-28.39x)

March 31, 2025

Industry (0.00x)

October 30, 2025

Today (112.78x)

October 30, 2025

Highest (-0.12x)

December 31, 2020

LowHigh

Today’s Price to Earnings Ratio: 112.78x

Delcath Systems Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Delcath Systems Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Delcath Systems Inc	BUY	$355.1M	-9.24%	112.78	3.18%
Boston Scientific Corp.	BUY	$149.6B	192.68%	53.99	14.43%
Stryker Corporation	BUY	$143.7B	82.96%	49.73	12.25%
Abbott Laboratories	BUY	$220.4B	18.38%	15.91	31.88%
Edwards Lifesciences Corp.	BUY	$48.5B	15.34%	34.6	72.96%

See all

Stock Returns calculator for Delcath Systems Inc Stock including INR - Dollar returns

The Delcath Systems Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Delcath Systems Inc investment value today

Current value as on today

₹95,619

Returns

₹4,381

(-4.38%)

Returns from Delcath Systems Inc Stock

₹10,048 (-10.05%)

Dollar Returns*

₹5,667 (+5.67%)

Analyst Recommendation on Delcath Systems Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Delcath Systems Inc. Average target price of $23.5

Delcath Systems Inc Share Price Target

Get share price movements and forecasts by analysts on Delcath Systems Inc.

What analysts predicted

60%UPSIDE

Target Price

$23.5

Current Price

$9.4

Analyzed by

11 Analysts

Target

$23.50

Delcath Systems Inc target price $23.5, a slight upside of 60% compared to current price of $9.4. According to 11 analysts rating.

Delcath Systems Inc Stock’s Investor Sentiment and Interest

Search interest for Delcath Systems Inc Stock has increased by 169% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 1, 2025 to October 31, 2025

Change:169% versus previous 30 day period

Delcath Systems Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	3	7	9	15	19	24
Gross Profit	0	0	0	0	2	6	9	12	16	20
Operating Income	-8	-7	-10	-11	-10	-3	-1	3	0	2
EBITDA	-8	-6	-19	-11	-10	-13	-1	10	0	3
Interest Expense	0	0	0	0	0	0	0	-	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	-7	-20	-11	-11	-13	1	-3	1	3
Income Tax Expense	1	0	0	-1	0	-	-	-	0	0
Net Income	-9	-7	-20	-11	-11	-13	1	-3	1	2
Net Profit Margin	-1507.54%	-1454.95%	-4686.64%	-2066.05%	-353.97%	-176.94%	19.50%	-22.50%	5.40%	11.16%

Delcath Systems Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	1	2	3	1	1	3	2	2	37
Gross Profit	1	1	2	2	0	1	2	2	1	31
Operating Income	-15	-16	-18	-27	-19	-21	-24	-33	-38	-12
EBITDA	-14	-16	-23	-10	-2	-23	-23	-33	-46	-12
Interest Expense	0	14	21	7	4	0	1	2	1	-
Depreciation	-	-	0	0	1	0	0	0	0	0
Income Before Tax	-14	-17	-45	-19	-8	-24	-25	-36	-47	-26
Income Tax Expense	-1	14	21	15	4	0	1	2	0	-
Net Income	-14	-17	-45	-19	-13	-24	-26	-39	-47	-26
Net Profit Margin	-841.67%	-902.16%	-1661.77%	-564.19%	-862.47%	-1487.55%	-752.66%	-1440.35%	-2308.86%	-70.92%

Delcath Systems Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-7	-20	-11	-11	-13	1	-3	1	2
Operating Cash Flow	-9	-9	-8	-9	-4	-3	-1	2	7
Investing Cash Flow	0	0	-19	4	10	0	-15	-25	0
Financing Cash Flow	0	35	0	4	-2	-2	40	3	14
Change in Cash	-9	25	-27	0	2	-6	24	-19	21

Delcath Systems Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-17	-45	-19	-8	-24	-25	-36	-47	-26
Operating Cash Flow	-14	-15	-14	-23	-22	-22	-24	-31	-18
Investing Cash Flow	-1	0	0	0	0	0	0	-19	0
Financing Cash Flow	7	15	13	30	42	20	10	51	39
Change in Cash	-8	0	-1	6	18	-1	-15	0	19

Global Institutional Holdings in Delcath Systems Inc

Funds	Holdings
Rosalind Advisors, Inc.	9.43%
BlackRock Inc	4.91%
Vanguard Group Inc	4.6%
Deerfield Management Co	2.32%
Citadel Advisors Llc	2.3%

See all

Insights on Delcath Systems Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, DCTH has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 years, DCTH stock has moved up by 237.5%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 8 quarters, 434.0K → 24.15M (in $), with an average increase of 37.0% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -3.39M → 2.69M (in $), with an average increase of 239.1% per quarter
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 23.4% return, outperforming this stock by 34.1%

About Delcath Systems Inc

delcath systems, inc. (nasdaq- dcth) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. our proprietary product---melphalan hydrochloride for injection for use with the delcath hepatic delivery system (melphalan/hds)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. delcath is in late-stage clinical development in the united states with initial commercial activities in europe, where the melphalan/hds is marketed as a ce marked device under the trade name delcath hepatic chemosat® delivery system for melphalan (chemosat). our commercial strategy for chemosat is to steadily grow clinical adoption in major european markets and utilize physician experience to support appeals for reimbursement. since launch over 250 chemosat treatments have been performed at over 20 leading european cancer centers. in 2016, we launched our focus pivotal study in hepatic dominant ocular

Organisation	Delcath Systems Inc
Headquarters	566 Queensbury Avenue, New York, NY, United States, 12804
Industry	Medical Specialties
CEO	Mr. Gerard J. Michel MBA, MS
E-voting on shares	Click here to vote

Key Management of Delcath Systems Inc

Name	Title
Mr. Gerard J. Michel MBA, MS	CEO & Director
Dr. Martha S. Rook Ph.D.	Chief Operating Officer
Dr. Vojislav Vukovic M.D., M.Sc., Ph.D.	Chief Medical Officer
Ms. Sandra Pennell CPA	Chief Financial Officer
Mr. David Hoffman J.D.	General Counsel, Corporate Secretary & Chief Compliance Officer
Dr. Johnny John M.D.	Senior Vice President of Clinical Operations & Medical Affairs
Dr. Michael Brunner M.D.	Senior Vice President of Interventional Oncology

FAQs

What is Delcath Systems Inc share price today?

Delcath Systems Inc share price today is $9.4 as on October 31, 2025 at 1:29 am IST at the close of the market. Delcath Systems Inc share today touched a day high of $9.98 and a low of $9.15.

What is the 52 week high and 52 week low for Delcath Systems Inc share?

Delcath Systems Inc share touched a 52 week high of $18.23 on May 20, 2025 and a 52 week low of $8.87 on November 15, 2024. Delcath Systems Inc stock price today i.e. October 31, 2025 at 1:29 am IST is closed at $9.4,which is 48.44% down from its 52 week high and 5.98% up from its 52 week low.

What is Delcath Systems Inc's market capitalisation today?

Delcath Systems Inc market capitalisation is $0.00T as on October 31, 2025 at 1:29 am IST.

How to invest in Delcath Systems Inc Stock (DCTH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Delcath Systems Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Delcath Systems Inc Shares that will get you 0.1596 shares as per Delcath Systems Inc share price of $9.4 per share as on October 31, 2025 at 1:29 am IST.

What is the minimum amount required to buy Delcath Systems Inc Stock (DCTH) from India?

Indian investors can start investing in Delcath Systems Inc (DCTH) shares with as little as ₹88.686 or $1 (as of October 31, 2025 at 8:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.86 in Delcath Systems Inc stock (as per the Rupee-Dollar exchange rate as on October 31, 2025 at 8:41 am IST). Based on Delcath Systems Inc share’s latest price of $9.4 as on October 31, 2025 at 1:29 am IST, you will get 1.0638 shares of Delcath Systems Inc. Learn more about fractional shares .

What are the returns that Delcath Systems Inc has given to Indian investors in the last 5 years?

Delcath Systems Inc stock has given -9.24% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?